Published in Neurogastroenterol Motil on December 09, 2009
The brain-gut axis in abdominal pain syndromes. Annu Rev Med (2011) 1.68
Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology (2011) 0.96
Macrophages in diabetic gastroparesis--the missing link? Neurogastroenterol Motil (2014) 0.86
Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev Diabet Stud (2011) 0.84
Gastric electrical stimulation for treatment of clinically severe gastroparesis. J Minim Access Surg (2013) 0.82
Comparison of manual and semiautomated techniques for analyzing gastric volumes with MRI in humans. Am J Physiol Gastrointest Liver Physiol (2014) 0.80
Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome. Gastroenterol Res Pract (2013) 0.80
Metoclopramide in the treatment of diabetic gastroparesis. Expert Rev Endocrinol Metab (2010) 0.79
Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility. Cell Mol Gastroenterol Hepatol (2016) 0.79
Oxytocin prolongs the gastric emptying time in patients with diabetes mellitus and gastroparesis, but does not affect satiety or volume intake in patients with functional dyspepsia. BMC Res Notes (2012) 0.78
Mirtazapine treatment of diabetic gastroparesis as a novel method to reduce tube-feed residual: a case report. J Med Case Rep (2013) 0.78
Somatic Complaints Are Significantly Associated with Chronic Uninvestigated Dyspepsia and Its Symptoms: A Large Cross-sectional Population Based Study. J Neurogastroenterol Motil (2017) 0.78
Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy. BMC Res Notes (2013) 0.78
Gastroparesis in children. Ann Gastroenterol (2013) 0.78
Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies. World J Gastroenterol (2014) 0.77
Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: a systematic review. World J Gastroenterol (2014) 0.77
Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based Pain. Pharmaceuticals (Basel) (2010) 0.76
The search for biomarkers and endophenotypes in functional gastrointestinal disorders. Gastroenterology (2011) 0.75
Microangiopathy is common in submucosal vessels of the colon in patients with diabetes mellitus. Rev Diabet Stud (2014) 0.75
Synthesis of a DOTA (Gd3+)-conjugate of proton-pump inhibitor pantoprazole for gastric wall imaging studies. Bioorg Med Chem Lett (2012) 0.75
Transcutaneous intraluminal impedance measurement for minimally invasive monitoring of gastric motility: validation in acute canine models. Gastroenterol Res Pract (2014) 0.75
Increased Expression of Pyloric ERβ Is Associated With Diabetic Gastroparesis in Streptozotocin-Induced Male Diabetic Rats. Gastroenterology Res (2016) 0.75
Characterization of Electrophysiological Propagation by Multichannel Sensors. IEEE Trans Biomed Eng (2015) 0.75
Gastroparesis as the Sole Presenting Feature of Neuromyelitis Optica. ACG Case Rep J (2017) 0.75
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell (2008) 14.17
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
Targeted disruption of the neuronal nitric oxide synthase gene. Cell (1993) 5.02
Diabetic cardiovascular autonomic neuropathy. Circulation (2007) 4.58
Clinical practice. Diabetic gastroparesis. N Engl J Med (2007) 4.40
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology (1993) 4.14
Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron (2002) 3.92
Functional gastroduodenal disorders. Gut (1999) 3.74
Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology (2003) 3.66
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol (2007) 3.65
Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med (2001) 3.28
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Progenitors of interstitial cells of cajal in the postnatal murine stomach. Gastroenterology (2008) 2.85
Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci (1998) 2.84
Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes (2000) 2.63
Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil (2006) 2.61
Prospects for stem cell-based therapy. Cell (2008) 2.45
Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.44
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med (2002) 2.29
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology (2006) 2.26
Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology (2001) 2.25
Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology (2009) 2.19
American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil (2008) 2.16
Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology (1997) 2.13
A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol (2006) 2.10
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol (2003) 2.04
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res (2004) 1.88
Nitric oxide in gastrointestinal health and disease. Gastroenterology (2004) 1.87
Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology (2008) 1.86
Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut (1994) 1.83
Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology (2005) 1.79
Distribution of interstitial cells of Cajal and nitrergic neurons in normal and diabetic human appendix. Neurogastroenterol Motil (2007) 1.79
Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol (2007) 1.78
The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology (2008) 1.77
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Natural history of diabetic gastroparesis. Diabetes Care (1999) 1.74
Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol (2009) 1.73
Acupuncture for functional gastrointestinal disorders. J Gastroenterol (2006) 1.66
Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther (2007) 1.65
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (2001) 1.64
Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci (1989) 1.63
Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies. Nat Clin Pract Gastroenterol Hepatol (2007) 1.63
Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med (2000) 1.61
5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil (2008) 1.59
Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil (2008) 1.58
Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc (2008) 1.55
STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol (2007) 1.54
Interstitial cells of Cajal in diabetic gastroenteropathy. Neurogastroenterol Motil (2008) 1.54
Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1989) 1.51
Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes. Am J Gastroenterol (1997) 1.51
Role of infection in irritable bowel syndrome. J Gastroenterol (2007) 1.50
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest (2000) 1.49
Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol (2005) 1.49
Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc (2005) 1.48
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47
Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci (1996) 1.47
Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol (1999) 1.47
Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004. Am J Gastroenterol (2007) 1.45
[New drugs; exenatide and sitagliptin]. Ned Tijdschr Geneeskd (2008) 1.40
The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol (1993) 1.38
Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) (2008) 1.37
Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther (2005) 1.34
Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology (2009) 1.33
Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology (2006) 1.33
Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol (2008) 1.32
Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial cells of Cajal in the murine stomach. Diabetes (2005) 1.31
Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol (2007) 1.30
American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology (2004) 1.30
Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice. Gastroenterology (2005) 1.29
A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc (2011) 1.29
Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology (2002) 1.28
Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci (2007) 1.28
A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol (1999) 1.26
Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci (2001) 1.25
Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther (2007) 1.24
Measurement of gastric emptying by magnetic resonance imaging in humans. Gastroenterology (1992) 1.24
Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol Motil (2009) 1.24
Electrical stimulation at a frequency higher than basal rate in human stomach. Dig Dis Sci (1997) 1.24
Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride. Scand J Gastroenterol (1992) 1.22
Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care (2004) 1.20
Diabetes and the enteric nervous system. Neurogastroenterol Motil (2007) 1.19
Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide. Neurogastroenterol Motil (2007) 1.16
Gender-related differences in gastric emptying. J Nucl Med (1987) 1.15
Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med (1995) 1.13
Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc (1989) 1.13
Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect (2007) 1.11
Scintigraphic validation of a magnetic resonance imaging method to study gastric emptying of a solid meal in humans. Gut (1999) 1.11
Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil (2001) 1.10
Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut (2006) 1.10
CD4+CD25+ suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol (2005) 1.07
Abnormal gastric motor function in viral gastroenteritis. Ann Intern Med (1980) 1.07
A rat model of chronic gastric sensorimotor dysfunction resulting from transient neonatal gastric irritation. Gastroenterology (2008) 1.06
Gastric meal accommodation studied by ultrasound in diabetes. Relation to vagal tone. Scand J Gastroenterol (1998) 1.06
Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil (2007) 1.06
Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol (2000) 6.40
Case-control study of phyto-oestrogens and breast cancer. Lancet (1997) 5.86
Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust (1999) 5.40
Context, composition and heterogeneity: using multilevel models in health research. Soc Sci Med (1998) 5.35
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
A molecular technique for identification of bacteria using small subunit ribosomal RNA sequences. Biotechniques (1994) 4.73
MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology (2002) 4.67
Novel mechanism for RNA maturation: the leader sequences of simian virus 40 mRNA are not transcribed adjacent to the coding sequences. Proc Natl Acad Sci U S A (1977) 4.64
Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology (1995) 3.95
Functional gastroduodenal disorders. Gut (1999) 3.74
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med (2000) 3.71
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc (2001) 3.62
Preclinical prediction of Alzheimer's disease using SPECT. Neurology (1998) 3.60
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med (2000) 3.57
Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet (1995) 3.35
Healing of duodenal ulcer with an antacid regimen. N Engl J Med (1977) 3.32
A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology (2000) 3.31
"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension (1990) 3.30
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A (1983) 3.17
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med (2001) 3.05
Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology (1990) 3.04
Pacemaking in interstitial cells of Cajal depends upon calcium handling by endoplasmic reticulum and mitochondria. J Physiol (2000) 3.02
Asthma care in general practice--time for revolution? Br J Gen Pract (1991) 2.93
The physiology and pathophysiology of gastric emptying in humans. Gastroenterology (1984) 2.93
Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant (2010) 2.87
Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci (1998) 2.84
Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system. Gut (1983) 2.83
Smoking and deprivation: are there neighbourhood effects? Soc Sci Med (1999) 2.79
Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut (1997) 2.77
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth (2000) 2.75
Measurement of systemic oxygen uptake during low-flow anaesthesia with a standard technique vs. a novel method. Anaesthesia (2002) 2.73
Smaller inner ear sensory epithelia in Neurog 1 null mice are related to earlier hair cell cycle exit. Dev Dyn (2005) 2.71
Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71
The primary health care non-team. BMJ (1994) 2.66
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology (1999) 2.64
A comparison of reinforcer assessment methods: the utility of verbal and pictorial choice procedures. J Appl Behav Anal (1996) 2.63
Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging (1995) 2.62
Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil (2006) 2.61
Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care (2001) 2.60
Prevention of varicella by zoster immune globulin. N Engl J Med (1969) 2.57
Health-related behaviour in context: a multilevel modelling approach. Soc Sci Med (1996) 2.57
Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril (1999) 2.52
Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil (2012) 2.49
Insulin coma therapy in schizophrenia. J R Soc Med (2000) 2.49
Integrating pharmacy fully into the primary care team. BMJ (1995) 2.47
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut (1987) 2.46
Oral contraceptives and breast cancer. Progress report of an epidemiological study. Lancet (1975) 2.46
Understanding the Italian Experience. Br J Psychiatry (1985) 2.41
Cyclic vomiting syndrome in adults. Neurogastroenterol Motil (2008) 2.40
Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology (1994) 2.39
Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology (1997) 2.39
Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology (1985) 2.37
Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther (2002) 2.37
Molecular technique for rapid identification of mycobacteria. J Clin Microbiol (1996) 2.37
Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther (2000) 2.34
HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci U S A (1999) 2.32
Genetic diversity of Campylobacter jejuni isolates from farm animals and the farm environment. Appl Environ Microbiol (2003) 2.32
Do places matter? A multi-level analysis of regional variations in health-related behaviour in Britain. Soc Sci Med (1993) 2.30
Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil (2004) 2.28
Clinical approaches to irritable bowel syndrome. Lancet (1992) 2.28
Explicit intraoperative recall at a Bispectral Index of 47. Anesth Analg (2001) 2.27
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Transgastric endoscopic splenectomy: is it possible? Surg Endosc (2006) 2.26
Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology (2001) 2.25
Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut (2002) 2.24
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Cryptosporidiosis in hospital personnel. Evidence for person-to-person transmission. Ann Intern Med (1985) 2.19
American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil (2008) 2.16
Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. J Virol (1992) 2.15
Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut (2008) 2.13
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med (1994) 2.13
Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci. Am J Hum Genet (1992) 2.12
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol (2002) 2.10
Stimulus and site specific induction of hiccups in the oesophagus of normal subjects. Gut (1997) 2.10
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
Asthma--still a challenge for general practice. J R Coll Gen Pract (1989) 2.08
P2X receptor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity. Gut (2008) 2.08
Isolation of vero cytotoxin-producing Escherichia coli O157 from wild birds. J Appl Microbiol (1997) 2.08
Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol (2001) 2.08
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
A double-blind comparison of quinine sulphate and placebo in muscle cramps. Age Ageing (1983) 2.07
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol (2001) 2.05
The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I. J Altern Complement Med (1998) 2.04